Identification of the Novel HLA‐B*55:02:18 Allele Using Nanopore Sequencing Technology
HLA · 2026-07 · 108 (1)
DOI: 10.1111/tan.70871 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 21.07.2026. Verfasst von Zhipan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-B Antigens, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical and Health Science Program of Zhejiang Province.
Abstract (Originalsprache)
HLA‐B*55:02:18 differs from HLA‐B*55:02:01:01 by one nucleotide substitution at position 963 G > A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Zhipan Wu, Fang Wang, Lina Dong, Yanmin He, Faming Zhu
Förderung
- Medical and Health Science Program of Zhejiang Province
Zitieren
APA
Wu, Z., Wang, F., Dong, L., He, Y., & Zhu, F. (2026). Identification of the Novel HLA‐B*55:02:18 Allele Using Nanopore Sequencing Technology. HLA, 108(1). https://doi.org/10.1111/tan.70871
Vancouver
Wu Z, Wang F, Dong L, He Y, Zhu F. Identification of the Novel HLA‐B*55:02:18 Allele Using Nanopore Sequencing Technology. HLA. 2026;108(1). doi:10.1111/tan.70871
BibTeX
@article{Wu2026,
author = {Wu, Zhipan and Wang, Fang and Dong, Lina and He, Yanmin and Zhu, Faming},
title = {Identification of the Novel HLA‐B*55:02:18 Allele Using Nanopore Sequencing Technology},
journal = {HLA},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/tan.70871}
}
EUVIMED